Atlas Trials

Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis

Clinical trial NCT00970346 · COMPLETED

Trial details

NCT number
NCT00970346
Sponsor
AlgiPharma AS
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2009-09-01
Primary completion
2009-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.